Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Evaluation of the health risks related to the presence of cyanogenic glycosides in foods other than raw apricot kernels

EFSA Panel on Contaminants in the Food Chain (CONTAM) et al. EFSA J. .

Abstract

In 2016, the EFSA Panel on Contaminants in the Food Chain (CONTAM) published a scientific opinion on the acute health risks related to the presence of cyanogenic glycosides (CNGs) in raw apricot kernels in which an acute reference dose (ARfD) of 20 μg/kg body weight (bw) was established for cyanide (CN). In the present opinion, the CONTAM Panel concluded that this ARfD is applicable for acute effects of CN regardless the dietary source. To account for differences in cyanide bioavailability after ingestion of certain food items, specific factors were used. Estimated mean acute dietary exposures to cyanide from foods containing CNGs did not exceed the ARfD in any age group. At the 95th percentile, the ARfD was exceeded up to about 2.5-fold in some surveys for children and adolescent age groups. The main contributors to exposures were biscuits, juice or nectar and pastries and cakes that could potentially contain CNGs. Taking into account the conservatism in the exposure assessment and in derivation of the ARfD, it is unlikely that this estimated exceedance would result in adverse effects. The limited data from animal and human studies do not allow the derivation of a chronic health-based guidance value (HBGV) for cyanide, and thus, chronic risks could not be assessed.

Keywords: cyanide; cyanogenic glycosides; health‐based guidance values; risk assessment.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Chemical structures of linamarin and linustatin
Figure 2
Figure 2
Biosynthesis of linamarin

  1. CYP: cytochrome P450; Glc: glucose; UDP‐Glc: uridine diphosphoglucose; UGT: uridine diphosphoglucosyltransferase.

Figure 3
Figure 3
Formation of HCN from linamarin

  1. Glc: glucose; HNL: hydroxynitrile lyase.

Figure 4
Figure 4
Detoxification of cyanide ions (from EFSA CONTAM Panel, 2016)

  1. ATCA: 2‐amino‐2‐thiazoline‐4‐carboxylic acid; α‐KG: α‐ketoglutarate; α‐KGCN: α‐ketoglutarate cyanhydrin

Figure 5
Figure 5
Distribution of analytical results
Figure C.1
Figure C.1
Individual and mean (in bold) concentration–time curves observed after ingestion of the four foods (persipan paste, apricot kernels, linseed, cassava) (taken from Abraham et al., 2016)
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Abraham K, Buhrke T and Lampen A, 2016. Bioavailability of cyanide after consumption of a single meal of foods containing high levels of cyanogenic glycosides: a crossover study in humans. Archives of Toxicology, 90, 559–574. - PMC - PubMed
    1. Adamolekun B, 2010. Etiology of Konzo, epidemic spastic paraparesis associated with cyanogenic glycosides in cassava: role of thiamine deficiency? Journal of Neurological Sciences, 296, 30–33. 10.1016/j.jns.2010.06.016 - DOI - PubMed
    1. Adeparusi EO, 2001. Effect of processing on the nutrients and anti‐nutrients of lima bean (Phaseolus lunatus L.). Nahrung/Food, 45, 94–96. - PubMed
    1. Adewusi SR and Oke OL, 1985. On the metabolism of amygdalin. 2. The distribution of beta‐glucosidase activity and orally administered amygdalin in rats. Canadian Journal of Physiology and Pharmacology, 63, 1084–1087. - PubMed
    1. Adindu MN, Olayemi FF and Nze‐Dike OU, 2003. Cyanogenic potential of some cassava products in Port Harcourt markets in Nigeria. Journal of Food Composition and Analysis, 16, 21–24.